Roche launches two new cyclospora tests as US outbreak widens
Roche Backs Full-Year View as First-Half Sales Rise
Roche confirms full year targets as first-half sales fall
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
FDA approves first generic version of Roche's flu drug
Roche sticks to German investment after Eli Lilly cuts
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial
Isomorphic Labs' $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
Roche gets second European approval for Alzheimer's test
Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
Switzerland's Roche agrees to acquire US-based PathAI
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Roche Backs Full-Year View as Quarterly Sales Rise
Roche Q1 sales down on forex effects
Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
Roche launches new Elevidys study after feedback from European regulator
C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion